-
AUD/USD: Trading the Reserve Bank of Australia Interest Rate Decision
Friday, July 29, 2011 - 4:16pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
6 Safe Stocks for an Inflation Proof Portfolio
Friday, July 29, 2011 - 4:11pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
US Debt Ceiling Negotiations At Risk as Boehner Plan Vote Looms
Friday, July 29, 2011 - 3:57pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
6 Companies That Could Be Acquired This Year
Friday, July 29, 2011 - 3:56pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
8 REITs at High Risk of Cutting Dividends and 3 Safer Options
Friday, July 29, 2011 - 3:53pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
10 Stocks Near $30 That Could Trade for $40
Friday, July 29, 2011 - 3:50pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
5 Core Dividend Stocks Underappreciated by Investors
Friday, July 29, 2011 - 3:47pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
Invest Like a Billionaire: John Paulson's 6 New Stock Picks
Friday, July 29, 2011 - 3:44pm | 279With the knowledge that the lion's share of all potential drugs will fail, investing in the biotech sector can sometimes be compared to high stakes gambling. With that in mind, today we take a look at six potentially undervalued biotech stocks. Oncothyreon Inc. (ONTY): This clinical-stage...
-
Jazz Pharmaceuticals Soaring 15%
Friday, July 29, 2011 - 3:12pm | 88Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) shares are soaring today, gaining more than 15% after the company reported earnings last night. The company reported earnings that beat Wall Street estimates and raised 2011 earnings estimates. The company said it expects to earn $2.68 to $2.79 per share...
-
Pfizer Provides U.S. Regulatory Update on Prevnar 13 for Use in Adults 50 Years and Older
Friday, July 29, 2011 - 2:20pm | 175Pfizer Inc (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has issued a 90-day extension to the action date for the Company's supplemental Biologics License Application (sBLA) for use of Prevnar 13®, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein...
-
U.S. Court of Appeals Affirms Validity of Lilly's Strattera Patent
Friday, July 29, 2011 - 12:35pm | 90Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has overturned a prior ruling by the U.S. District Court for the District of New Jersey and has upheld the validity of the company's method-of-use patent on Strattera® (atomoxetine). In the...
-
Jazz Pharmaceuticals up 14% on Upbeat Earnings
Friday, July 29, 2011 - 11:06am | 45Jazz Pharmaceuticals (NASDAQ: JAZZ) is up 14% on the upbeat earnings reported yesterday after the close. The company reported Q2 EPS $0.82 vs $0.77 Est; Revenues $64.6M vs $61.86M Est. Jazz Pharmaceuticals is currently trading at $40.12, a gain of $4.85 or 13.75%.
-
Earnings Preview: Allergan's EPS, Revenue Expected to Rise
Friday, July 29, 2011 - 10:05am | 582Allergan (NYSE: AGN) unveils its next round of earnings this Wednesday, August 3, 2011. Here is Benzinga's everything-that-matters guide for this Wednesday's second quarter earnings announcement. Earnings and Revenue: Ahead of the company's earnings announcement, analysts are expecting a...
-
UPDATE: Stifel Nicolaus Downgrades ISTA Pharmaceuticals to Hold
Friday, July 29, 2011 - 8:49am | 67Stifel Nicolaus is out with its report today on ISTA Pharmaceuticals (NASDAQ: ISTA), downgrading ISTA to Hold. In its report, Stifel Nicolaus writes, "We move to the sidelines and downgrade ISTA to Hold, under the view that shares are fairly valued. We await signs of renewed momentum in the...
-
Stifel Nicolaus Downgrades CTCT, ISTA To Hold
Friday, July 29, 2011 - 8:04am | 43Stifel Nicolaus has downgraded the following companies: Constant Contact (NASDAQ: CTCT) from Buy to Hold, $36 PT removed ISTA Pharmaceuticals (NASDAQ: ISTA) from Buy to Hold, $13 PT removed